- Key Insight: Discover how skyrocketing specialty drug costs force benefit strategies toward hyper-personalized enrollment.
- What’s at Stake: Employer premiums, talent retention, and insurer solvency face rising fiscal and legal pressure.
- Forward Look: Prepare for OBBBA and ACA subsidy changes to materially increase commercial premiums in 2026.
- Source: Bullets generated by AI with editorial review
Preparing for open enrollment: Advisers face significant headwinds in Q4

Bruce Shutan is an Employee Benefit News contributing writer based in Portland, Oregon.